PEGylation can improve solubility or alter hydrodynamic behavior, but it also makes synthesis, purification and analysis less straightforward. “Peptide plus 2 kDa PEG” is not a complete material definition. When selecting a custom PEGylated peptide synthesis supplier, specify polymer architecture, attachment site, linker and distribution before comparing purity claims.
Define the PEG reagent, not only nominal size
State linear or branched architecture, nominal molecular weight, end groups, reactive functionality and whether the PEG is monodisperse or polydisperse. Conventional polymeric PEG contains a molecular-weight distribution; discrete PEG reagents can have a defined repeat count. These materials produce different MS patterns and acceptance criteria.
Request the PEG reagent specification and lot traceability. Residual reactive PEG, hydrolyzed PEG and PEG-related impurities can persist even when the peptide chromatogram looks acceptable.
Control the conjugation site
N-terminal amine, lysine side chain, cysteine thiol or an engineered handle can support conjugation. If several reactive groups are available, positional isomers may form. They can share intact mass and overlap by reversed-phase HPLC while behaving differently in the intended research system.
Use selective protection, orthogonal chemistry or an engineered unique handle to reduce heterogeneity. The specification should name the attachment residue and linker. “Mono-PEGylated” describes the number of PEG chains, not their position.
Review conversion and purification separately
Driving conjugation with excess reagent can improve conversion but increases the free-PEG burden. Free polymer may lack strong UV absorbance, making peptide-wavelength HPLC a poor detector. Size-exclusion, evaporative light-scattering, charged-aerosol detection or other suitable methods may be needed.
Ask for a reaction-monitoring profile, preparative recovery and final impurity assessment. A broad PEG distribution can create wide peaks that tempt aggressive integration. Integration rules should be defined before release.
Mass spectrometry has practical limits
A discrete PEG conjugate may yield interpretable charge states and exact mass. A polydisperse conjugate creates a series of peaks separated by repeat-unit mass and can be difficult to deconvolute. Ionization response may differ between free peptide, conjugate and PEG-related species.
LC-MS can confirm expected components, but it may not quantify every distribution accurately. Combine it with HPLC, SEC and polymer-sensitive detection as appropriate. For positional identity, tandem MS or mapping around the conjugation site may be required.
SEC results need recovery controls
PEG increases hydrodynamic size, so globular protein calibration can overestimate apparent molecular weight. Use SEC primarily to monitor free peptide, conjugate-related species and aggregates under a qualified method. Check column interaction and total recovery.
Low-bind sample handling matters. PEGylated constructs may behave better in aqueous solution than the parent peptide, yet a hydrophobic sequence or linker can still adsorb or associate.
Content and packaging affect comparability
Gross weight includes counterion, water, free polymer and residual materials. Define whether the delivered amount is conjugate mass, peptide-equivalent content or moles of the complete construct. The calculation must match the research protocol.
Request aliquots sized for single-study use, protected from moisture and repeated freeze-thaw. Shipping and storage conditions should be supported for the conjugate rather than copied from the unconjugated peptide.
- Exact peptide, PEG architecture, linker and attachment site.
- PEG reagent identity, distribution and lot records.
- Free peptide, free PEG and multi-PEG species limits.
- HPLC, LC-MS, SEC and site-confirmation evidence.
- Content basis, water, counterion and vial-fill specification.
What purity number should a buyer request? There is no single value that captures positional purity, polymer distribution and free PEG. Set separate acceptance criteria for the target conjugate and relevant impurity classes.
Send the sequence, intended attachment site, PEG definition, desired scale and downstream assay with the RFQ. A technically capable supplier should explain how conjugation, purification and release testing will change when moving from a feasibility lot to bulk supply.